Rating date
May 29, 2026
73 days ago
Pfizer (PFE) Stock Analysis
HOLDPFE Equity Research — HOLD — May 2026
Desk view
HOLD
5D move
—
Neutral (HOLD unscored)
Peer rank
53p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · PFE
Multiple outlets (GuruFocus, Quartz, Pharmaceutical Technology) covered the mega-deal. Pfizer will co-develop 12 early-stage oncology programs with Innovent, spanning immuno-oncology and antibody-drug conjugates. The $650 million upfront...
Desk rating
HOLD
Tactical HOLD · 12M HOLD
Horizon
Long-term
Confidence
Medium
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
HOLD
Catalysts
- PFE has been in a clear long-term uptrend since April 2025, but the last month shows a sideways-to-slightly-lower consolidation.
- Volatility has contracted meaningfully (ATR –21%), suggesting a quiet period that historically resolves with a larger move.
- Momentum is improving: RSI has climbed out of oversold territory and MACD histogram turned positive on 21 May.
Risks
- Event-driven repricing risk if expectations diverge from incoming evidence.
Market chart
Price context alongside the research narrative.
PFE Research Note
Full desk note for May 29, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
PFE Equity Research Note
PFE Stock Rating Summary
PFE bias
HOLD
Horizon
Long-term
PFE key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
PFE catalyst watch
PFE has been in a clear long-term uptrend since April 2025, but the last month shows a sideways-to-slightly-lower consolidation.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Medium
How the call aged · 5D
—Neutral (HOLD unscored)Peer 53pExpandCollapse
How the call aged · 5D
—Neutral (HOLD unscored)Peer 53p
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-05-30T11:24:27.135260+00:00.
5D move
—
2026-05-29 → awaiting
Outcome
Neutral (HOLD unscored)
5D trend
+0.89%
Vol (20D ann.)
+12.60%
vs SPY: -0.97%
Close 26.18 → — (USD, vendor closes)